(Q24185945)

3

0 references

Elvira C. van Dalen

4

object named as

Elvira C van Dalen

0 references

Leontien C Kremer

7

object named as

Leontien CM Kremer

0 references

author name string

Lianne M Haveman

1

0 references

Willemijn B Breunis

2

0 references

Emilia C Owers

5

0 references

Uta Dirksen

6

0 references

Henk van den Berg

9

0 references

Johannes HM Merks

Cochrane Database of Systematic Reviews

10

0 references

publication date

12 April 2016

0 references

published in

0 references

cites work

Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012133

Pediatric FDG PET/CT: Physiologic uptake, normal variants, and benign conditions [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012133

FDG PET/CT imaging in primary osseous and soft tissue sarcomas: a retrospective review of 212 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012133

Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012133

Sarcoma tumor FDG uptake measured by PET and patient outcome: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012133

Molecular imaging of cancer with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012133

Children's Oncology Group's 2013 blueprint for research: bone tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012133

Impact of FDG PET for staging of Ewing sarcomas and primitive neuroectodermal tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012133

[18F]Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012133

The hazards of scoring the quality of clinical trials for meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012133

Imaging pediatric bone sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012133

Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012133

PET/CT in primary musculoskeletal tumours: a step forward

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012133

Ewing sarcoma: historical perspectives, current state-of-the-art, and opportunities for targeted therapy in the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012133

PET/CT in the evaluation of childhood sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012133

An evaluation of [F-18]-fluorodeoxy-D-glucose positron emission tomography, bone scan, and bone marrow aspiration/biopsy as staging investigations in Ewing sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012133

Ewing sarcoma: biology-based therapeutic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012133

Clinical applications of positron emission tomography in sarcoma management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012133

Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012133

Positron emission tomography-adapted therapy for first-line treatment in individuals with Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012133

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012133

Ewing sarcoma demonstrates racial disparities in incidence-related and sex-related differences in outcome: an analysis of 1631 cases from the SEER database, 1973-2005

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012133

7 January 2021

The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma (PDMES)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012133

7 January 2021

Evaluation of chemotherapy response in primary bone tumors with F-18 FDG positron emission tomography compared with histologically assessed tumor necrosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012133

7 January 2021

Is there a common SUV threshold in oncological FDG PET/CT, at least for some common indications? A retrospective study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012133

7 January 2021